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Abstract 
 
Background: Eight plant species from Oaxaca, some of them used in traditional medicine, were subjected to screening 
of several biological activities to provide data regarding their anticancer potential, although no scientific information is 
available about their pharmacological effects. 
Materials and methods: Methanol extracts from stems or roots of the eight plants were tested for antioxidant activity 
by the DPPH· method.  Antimicrobial activity was determined using the agar diffusion method and the minimal 
inhibitory concentration (MIC) was obtained by broth dilution method. Antitopoisomerase activity was assessed using 
mutant strains of Saccharomyces cerevisiae JN362a, JN394, JN394t-1, JN394t2-4 and JN394t2-5. The mutagenic activity 
was evaluated using the Ames test (Salmonella typhimurium TA1535). 
Results: No extract showed significant antioxidant activity. The best antimicrobial activity was observed for 
Salpianthus arenarius (MIC 56.25 μg/mL) and Lantana achyranthifolia (MIC 78.12 μg/mL) against Staphylococcus 
aureus. Extracts of Acalypha cuspidata, Alloispermum integrifolium and L. achyranthifolia stems showed 
antitopoisomerase II activity with JN394t-1 growth of -30.88±0.0%, -38.11±4.95%, and -70.97±12.02% respectively.  
Galium mexicanum stem extract showed antitopoisomerase I activity with growth of 35.31±6.36% on the same mutant 
strain. All plant extracts were non-mutagenic. Fractionation of A. cuspidata extract led to identification of two 
subfractions with antitopoisomerase I and II activity at 154μg/mL (Positive controls 50 and 100μg/mL).  
Conclusion: Methanol extracts of A. cuspidata, A. integrifolium, G. mexicanum, and L. achyranthifolia stems showed 
antitopoisomerase and non-mutagenic activities, and consequently could be promising as a source of anticancer drugs. 
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Introduction 
 
In the search for bioactive compounds from vegetal species, the value of ethno-medicine and traditional 
pharmacology is recognized to increase the probability of finding new molecules with useful biological activities in the 
treatment of diseases or disorders, such as cancer, with important economic and social impact. Established anticancer 
drugs from plants have had significant influence on the study of anticancer molecular mechanisms and have provided 
new structural models for future drugs to treat or prevent cancer (Khazir et al., 2014).  The research to discover these 
bioactive compounds is based on several biological tests. In vitro bioassays were used to evaluate the anticancer 
activity of a compound. These assays examined antimicrobial activity, which allows the identification of novel agents 
capable of interfering with a specific molecular target. These may avoid the shortcomings of conventional 
chemotherapy because certain antimicrobials exhibit selective cytotoxicity against a broad spectrum of human cancer 
cells (Schweizer, 2009). Assays to determine the topoisomerases inhibition mechanism were done.  This mechanism is 
considered an attractive targeting strategy in both chemotherapy and chemoprevention because antitopoisomerase 
agents showed potential to inhibit carcinogenesis via antiproliferative or cell-differentiating action (Cho et al, 2000).  
Antioxidant activity was investigated because potent scavengers of Reactive Oxygen Species (ROS) may serve as a 
possible preventive intervention for free radical-mediated diseases such as cancer (Ralph et al., 2010).  
In Mexico, ethnomedicine has led to knowledge of some useful plants for the treatment of cancer (Alonso-
Castro et al., 2011), however there is a lack of scientific evidence about biological activity of most of them. Therefore, 
the aim of the present study is to evaluate the anticancer potential of eight vegetal species from Oaxaca, belonging to 
six botanic families (Asteraceae, Euphorbiaceae, Rubiaceae, Verbenaceae, Nictaginaceae and Boraginaceae), which are 
used in traditional medicine (Table 1), by screening the antioxidant, antimicrobial, and antitopoisomerase activities of 
methanol extracts of stems or roots of each specie. Additionally, two antitopoisomerase fractions were obtained from 
an active extract.  Mutagenic evaluation using Salmonella thyphimurium TA1535 strain was done to investigate the 
possible toxic effects of vegetal extracts in addition to their medicinal properties (Déciga-Campos et al., 2007). 
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Materials and Methods 
Biological material 
 
Dr. John Nitiss of St. Jude Children’s Research Hospital, Memphis, Tennessee, kindly provided 
Saccharomyces cerevisiae mutant cells JN362a, JN394, JN394t-1 JN394t2-4 and JN394t2-5. Standard microorganisms 
were purchased from American Type Culture Collection (ATCC, Manassas, VA) and from National Collection of 
microbial and cell cultures of CINVESTAV-IPN (CDBB, México, D.F.).  These included Salmonella thyphimurium 
TA1535, a histidine-mutant bacterial strain obtained from ATCC and used in antimutagenicity experiments, and Gram 
negative bacteria Klebsiella pneumoniae (CDBB-B-1024), Escherichia coli (CDBB-B-1000), Proteus mirabilis 
(ATCC12453) and Proteus vulgaris (ATCC49132). Gram positive bacteria; Staphylococcus aureus (CDBB-B-1005) 
and Staphylococcus epidermidis (CDBB-B-1012) and the fungus Candida albicans (CDBB-L-1003) were also 
purchased for use in this work. 
  
Chemicals 
 
All extracting and column chromatography (CC) reagents were reagent grade. Merck silica gel (100-200 mesh 
ASTM) was used for CC chromatography. TLC was performed on precoated silica gel aluminum sheets (silica gel 60 
F254, 0.20 mm, Merck). Fractions were monitored by UV (254 nm), and by a ceric sulfate reagent followed by heating.  
Peptone bacto, yeast extract, agar bacto, Mueller Hinton (MH) agar, MH broth, trypticase soy agar, Luria broth (LB), 
trypticase soy broth, sabouraud dextrose agar, sabouraud dextrose broth, minimal glucose agar (MGA) and dextrose 
were purchased from Difco (Sparks, MD). Methanol (HPLC grade), methanol (spectrophotometric grade), 
camptothecin (CPT), etoposide (ETP), dimethyl sulfoxide (DMSO-Hybri-Max), adenine hemisulfate salt, 
chloranphenicol, nystatin, ascorbic acid, 2,2-diphenyl-1-picrylhydrazyl (DPPH), benzo [a] pyrene (B[a]P), and sodium 
azide (NaN3) were obtained from Sigma Chemical (St. Louis, MO).  
 
Collection of plant material 
 
All vegetal species were collected in the State of Oaxaca, México.  Acalypha subviscida S. Watson var. 
lovelanddii McVaugh, Alloispermum integrifolium (DC.) H. Rob., and Galium mexicanum H.B.K. were collected in 
August 2012 in San Miguel Suchixtepec, Miahuatlán.  Acalypha cuspidata Jacq. (Euphorbiaceae) was collected in July 
2011 in Candelaria Loxicha, San Pedro Pochutla.  Adenophyllum aurantium (L.) Strother, Salpianthus arenarius Bonpl. 
(Nyctaginaceae) and Tournefortia densiflora M. Martens & Galeotti (Boraginaceae) were collected from the Chepilme 
Botanic Garden of the Universidad del Mar (UMAR), San Pedro Pochutla in July 2012. Lantana achyranthifolia Desf. 
(Verbenaceae) was collected in October 2010 in Huajuapan de León (Table 1). The vegetal material was identified at 
the genus and specie level by Gerardo Salazar Chávez Ph.D. from the Biology Institute of the Universidad Autónoma 
de México (UNAM), M. C. Ernestilla Cedillo Portugal and M. C. Lilian López Chávez from Universidad Autónoma de 
Chapingo. 
Plant samples were air-dried at room temperature without exposure to sunlight. The dry material was chopped 
into pieces and stored in a cool dry place until it was processed.  
 
Preparation of extracts 
 
 Organic extracts were prepared with 200 g of the stem (S), bulb (B) or root (R) of selected plants. Vegetal 
material was macerated with 1000 ml of methanol for two weeks at room temperature (25oC). The extracts were filtered 
using Whatman No 1 filter paper and the vegetal residue was further macerated twice with the same amount of solvent 
for one week more and filtered. The filtrates obtained from each extraction were mixed and concentrated until dry, 
under vacuum. All extracts were kept at 4oC for further use (Table 1). Prior to biological evaluation, each extract was 
dissolved in a minimum amount of dimetylsulfoxide (DMSO) to produce solutions free of solids. Concentration of each 
treatment for all tests, except mutagenicity, was based on the solubility factor of each solid extract in DMSO. These 
concentrations were 100 mg/ml for A. aurantium, A. aurantium (R), A. subviscida, A. integrifolium, L. achyranthifolia 
and T. densiflora; 50 mg/mL for A. cuspidata, G. mexicanum; 67 mg/mL for S. arenarius and 70 mg/ml for T. 
densiflora (R). 
 
Fractionation of A. cuspidata extract 
 
Methanol extract (13.0g) was subjected to silica gel column using hexane-ethyl acetate (Hx/AcOEt) mixtures 
of increasing polarity. All 287 fractions obtained were analyzed over TLC (SiO2, Hx: AcOEt) and grouped according to 
their chromatographic profile. This process resulted in 21 groups: AaA1 (7.37%). AaA2 (1.44%), AaA3 (1.08%), 
AaA4 (5.52%), AaA5 (1.41%), AaA6 (1.15%), AaA7 (0.58%), AaA8 (1.69%), AaA9 (0.54%), AaA10 (1.27%), 
AaA11 (1.13%), AaA12 (1.54%), AaA13 (0.68%), AaA14 (0.70%), AaA15 (2.13%), AaA16 (2.59%), AaA17 (5.09%), 
AaA18 (1.17%), AaA19 (3.41%), AaA20 (11.17%), and AaA21 (7.98%). AaA8 (200mg) was the only active fraction, 
so it was subjected to CC on reverse phase (C18) using methanol/water 1:1. Thirty-four eluates of 10 mL were 
collected and grouped in six sub-fractions: AaA8a (5.4%), AaA8b (28.5%), AaA8c (16.5%), AaA8d (17.2%), AaA8e 
(5.6%), AaA8f (1.9%). All fractions and sub-fractions were evaluated for antitopoisomerase activity. 
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Antioxidant activity of the extracts 
 
The antioxidant activity of extracts was assessed based on the scavenging activity of the stable 2,2-diphenyl-1-
picrylhydrazyl (DPPH•) free radical. A methanolic (spectrophotometric grade) solution (5µl) of the herbal extract at 
five different concentrations was added to 195 µl of DPPH• solution (7.6 x 10-5 M in methanol). When the reaction 
reached the steady state (in the absence of light), absorbance was measured at 515 nm in a microplate reader 
(Benchmark plus BIO-RAD) (Siddhuraju and Becker, 2003). The DPPH• concentration in the medium was calculated 
from the following calibration curve: 
A515nm = 0.0072 [DPPH•] T – 0.0097, where [DPPH•] T was expressed as µM and correlation coefficient (r2) = 0.999. 
 
The percentage of remaining DPPH• (% DPPH•REM) at the steady state was calculated as follows: 
 
% DPPH• REM = {[DPPH•] T /[DPPH•] T=0} × 100 
 
Where [DPPH•] T was the concentration of DPPH• at the time of steady state and [DPPH•] T=0 was the concentration of 
DPPH• at zero time. The % DPPH• REM against the standard concentration was plotted to obtain the amount of sample 
necessary to decrease the initial DPPH• concentration (EC50, g/kg DPPH) by 50%.  The time needed to reach the steady 
state to EC50 concentration (TEC50) was calculated graphically and the Antiradical Efficiency (AE), which represents Kg 
DPPH/g sample, was calculated by the equation: AE=1/(EC50TEC50) (Sánchez-Moreno et al. 1998). Ascorbic acid was 
used as a reference standard. All experiments were carried out in triplicate. The activity of each extract was expressed 
as a percentage of that achieved for the ascorbic acid. 
 
Antimicrobial screening 
 
The test microorganisms used in this study included six bacteria species, four Gram negative (K. pneumoniae, 
E. coli, P. mirabilis, and P. vulgaris), two Gram positive (S. aureus, S. epidermidis) and the fungus C. albicans.  
Antimicrobial activity was tested using the agar diffusion method using a cell suspension of approximately 1.5×106 
CFU/ml (colony forming units per milliliter) obtained using a 0.5 McFarland turbidity standard. The bacterial strains 
were inoculated in plates of trypticase soy agar and the fungus in plates of sabouraud dextrose agar.  
For susceptibility testing, each 150 µl of adjusted bacterial or fungal suspension was spread on a sterile medium 
(trypticase soy agar or sabouraud dextrose agar) using sterile swabs. The positive controls employed were 
chloranphenicol (30 µg) and nystatin (100 units) for antibacterial and antifungal assays respectively. Application of the 
samples and controls (25 µl) was done directly in the solid medium. The application point was marked on the lower 
surface of the Petri dish. The preparations were left to diffuse. Subsequently the plates were incubated at 37oC for 24 h 
in the case of the bacteria; while the fungus was cultured at 30oC for 48 h. Plates were prepared using the same 
procedures without extract or positive control, but with DMSO (25 µl) and were equally set as negative controls. After 
incubation, the growth inhibition rings were quantified by measuring the diameter for the zone of inhibition (I.D.) in 
millimeters from the lower surface of the plates. All assays were carried out in triplicate. 
 
 Determination of minimal inhibitory concentration (MIC) 
 
The Greenwood method (Greenwood, 1989) was used to determine the MIC of all eight extracts against each 
test organism. Each extract (50 µl) was mixed with 950 µl of sterile water to get an X concentration. Eight sterile test 
tubes were arranged in a test tube rack and 1 ml of sterile water was pipetted into each test tube. Thereafter, there was a 
twofold serial dilution of the extract to obtain 1 ml of each one of the following concentrations: X/2, X/4, X/8, X/16, 
X/32, X/64, X/128 and X/256. Each test organism (1 ml = 5 x 105 CFU/ml) was pipetted into each of the test tubes 
containing the extract. The final concentrations were: X/4, X/8, X/16, X/32, X/64, X/128, X/256 and X/512. Finally, 
the tubes were incubated at 37oC for 24 h in the case of the bacteria, and the fungus was cultured at 30oC for 48 h. The 
MIC was recorded as the least concentration of extract that completely inhibited the growth of the test organism. 
 
Yeast antitopoisomerase assay 
 
The antitopoisomerase activity was assessed using mutant strains Saccharomyces cerevisiae JN362a, JN394, 
JN394 t-1, JN394t2-4 and JN394t2-5 (Nitiss and Nitiss, 2001). Yeast cells were grown in YPDA media at 30°C for 18 
hours in a shaking incubator. The logarithmically growing cells were then counted using a hematocytometer and 
adjusted to a concentration of 2x106 cells/ml. Yeast cells (6x106 cells) were incubated at 30°C (JN362a, JN394, 
JN394t2-4, JN394 t-1) or 25oC (JN394t2-4 and JN394t2-5) for 24 hours in the shaking incubator, with each extract 
dissolved in 50 μL DMSO. DMSO (1.66%) was used as the negative control. CPT (50 μg/ml), a topoisomerase I 
inhibitor; ETP (100 μg/ml), a topoisomerase II poison and SBZ (150 μg/ml), a topoisomerase II inhibitor, were the 
positive controls. Treated cells from each mixture were then duplicate plated to Petri dishes containing 1.75% agar 
Bacto solidified YPDA as media. Cells were incubated at growth temperature of 30°C (JN362a, JN394, JN394t2-4, 
JN394t-1) or 25oC (JN394t2-4 and JN394t2-5) for 48 hours. Antitopoisomerase activity was then measured by comparing 
the number of counted colonies in each plate to that of the negative control plate (DMSO).  
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Mutagenicity test 
 
A preliminary cytotoxic experiment was performed using the bacterial growth assay on nutrient agar plates to 
identify the concentration at which the extracts have no significant effect on the viability of Salmonella typhimurium 
TA1535. Each plant extract (5 or 10 mg/mL) was incubated with 100 µL of 15 h growing bacteria (1 x 109 UFC/mL) 
on LB medium and mixed with 2.5 mL of warm 0.6% top agar (NaCl/Agar). The mix was then added to nutrient agar 
plates, the plates were incubated at 37oC for 24 h and finally the colonies on triplicate plates were counted and 
compared to control plates containing no extracts. The concentration investigated hereafter for all extracts was 5 
mg/mL. To screen the mutagenic potential of the plant extracts, the reverse bacterial mutation assay was performed as 
described by Maron and Ames (1983).  Each plant extract (5 mg/mL) was preincubated with 100 µL of 15 h growing 
bacteria (1 x 109 UFC/mL) on LB medium at 37oC for 30 minutes, with and without the addition of S9 mix 
(microsomal fraction).  The incubated strain (TA1535) was then added to top agar containing 50 µM of histidine/biotin 
and poured on to MGA plates. Revertant colonies were counted after incubation at 37oC for 36-48 h. Spontaneous 
revertant colonies arising on plates containing neither mutagens nor extracts were also counted; DMSO was used as the 
negative control. Revertant colonies produced with NaN3 (1µg/plate) or 20 µM B[a]P with S9 mix were used as 
positive controls. The number of visible revertant colonies (His+) was counted in each treatment and blanks. For a 
treatment to be considered mutagenic in the Ames test, the number of His+ revertant colonies on the plates containing 
the treatments must be more than twice the number of His+ revertant colonies on the negative control plate (Fawole et 
al., 2009). All assays were done in triplicate. 
 
Table 1: Values of extraction yield (expressed as percentage of dry plant weight) obtained for eight different medicinal 
plants used in the treatment of infectious and chronic diseases in Mexico 
Plant species 
Family 
Traditional uses References Plant part 
collected 
Common name/Collection 
site/voucher number 
(%)Yield extracts 
/MeOH 
Acalypha cuspidata 
Euphorbiaceae 
 
Treatment of skin 
infections. 
Note a 
 
Stem and 
leaves 
Hierba de la araña Candelaria 
Loxicha 
UACh 25068 
3.1 
 
Acalypha subviscida 
Euphorbiaceae 
Treatment of skin 
infections. 
(UNAM, 2009) Stem and 
leaves 
Hierba del pastor 
San Miguel Suchixtepec 
UACh 24007 
9.8 
Adenophyllum 
aurantium (L.) Strother 
Asteraceae 
Treatment of 
gastro-intestinal 
disorders and  
Cancer. 
(Alonso-Castro 
et al., 2011)  
Stem and 
leaves 
Ruda montes 
Chepilme Botanic Garden 
UACh 25173 
9.8 
 
   Roots (R)  1.1b 
2.5 
Alloispermum 
integrifolium 
Astearaceae 
 
Plant (stem) 
infusion is used as 
hypoglycemic. 
(Andrade-Cetto 
and Heinrich, 
2005) 
Stem and 
leaves 
Prodijiosa  
San Miguel Suchixtepec 
UACh 24024 
7.2 
 
Galium mexicanum var 
mexicanum/ 
Rubiaceae 
 
Oral infusion of 
leaves is used as 
abortifacient 
(Andrade-Cetto, 
2009) 
Stem and 
leaves 
Pegarropa or pega pega 
San Miguel Suchixtepec 
UACh 23994 
7.6 
 
Oral infusion of 
leaves is used in 
the treatment of 
stomachache, 
diarrhea. 
(UNAM, 2009) 
Lantana achyranthifolia 
Verbenaceae 
 
Treatment of 
gastrointestinal 
disorders, hepatic 
and respiratory 
complaints, fever 
(Frei et al., 1998) 
  
 
Stem and 
leaves 
Cancerina 
Huajuapan de León 
UACh 25185 
3.9 
 
Salpianthus arenarius 
Nictaginaceae 
Hypoglycemic (Andrade-Cetto 
and Heinrich, 
2005) 
 
Stem and 
leaves 
Roots (R) 
Chichuca 
Chepilme Botanic Garden 
UACh 25084 
27.4 
 
Tournefortia densiflora  
Boraginaceae 
Stem is used for 
the treatment of 
gastrointestinal 
disorders. 
(Alonso-Castro 
et al., 2011)  
 
Stem and 
leaves 
Hierba del negro,  
Hoja de cáncer 
Chepilme Botanic Garden 
UACh 25221 
2.2 
 
   Roots (R)  3.6 
   
aA. cuspidata is recommended by the community of Candelaria, Loxicha. 
bSolvent AcOEt UACh Chapingo Autonomous University; MeOH methanol: AcOEt: ethylacetate 
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Statistical Analysis 
 
All statistical analyses were performed using Graph Pad Prism 6 Program for Windows. Dunnett posttest was 
used for comparison of two groups. Data are expressed as means ± standard deviation (SD). Analysis of variance was 
determined by one-way (ANOVA).  P value < 0.05 was considered as significant. 
 
Results 
  
In our search for natural products with anticancer activity, we prepared methanol crude extracts of eight native 
plants used in the treatment of degenerative or infectious diseases. No scientific information is available about the 
pharmacological, biological and toxicological effects of the plant extracts studied in this work. Moreover, there are no 
references about the medicinal use of A. cuspidata. However, in the rural community where the plant was collected, the 
population said that Acalypha cuspidata stems and leaves are useful to treat skin infections. Table 1 summarizes the 
plant species, the parts of plants used for extract preparation, the percentage of yield extracts as well as the voucher 
numbers of the eight plants tested. Organic extracts were subjected to antioxidant, antimicrobial, antitopoisomerase, 
and mutagenicity evaluations to justify further studies searching for new anticancer molecules. In addition, two 
fractions with antitopoisomerase activity were identified from A. cuspidata extract. 
 
Antioxidant activity 
 
An antioxidant assay was carried out for all plant extracts (Table 2) and only A. subviscida extract showed 
weak antioxidant activity (EC50 = 480.97±2.34 g/kg DPPH•, TEC50 = 1 ± 0.17 min, % AE = 31.04).  
 
Antimicrobial activity and MIC 
 
The results of antibacterial activity on six bacteria and one fungus (Table 3) indicated that all extracts (except 
A. aurantium R) showed inhibition in at least one strain (≥7.02 mm) and were tested for their MIC values. S. 
epidermidis was sensitive to S. arenarius (MIC = 130 µg/mL).  The extracts from A. cuspidata (97.65 µg/mL), L. 
achyranthifolia (78.12 µg/mL) and S. arenarius (56.25 µg/mL) showed better antimicrobial activities with MIC < 100 
µg/mL values, all of them tested against S. aureus (Table 4). 
 
Table 2: Estimation of free radical-scavenging activity of crude plant extracts of some Mexican flora from Oaxaca. 
Treatments EC50 g/kg DPPH TEC50 min AE x 10-3 % of efficiency 
Ascorbic acid 102.67 ± 2.34 1.45 ± 0.36 6.70 ± 0.00051 100 
A. aurantium 4599.61 ± 1.88 2.45± 0.45 0.08 ± 0.000008 1.19 
A. aurantium (R) 6576.54 ± 2.05 2.50± 1.00 0.06 ±0.000008 0.90 
A. integrifolium 9007.23 ± 2.62 0.78± 0.24 0.28 ± 0.00021 4.18 
A. subviscida 480.97 ± 3.15 1.00± 0.17 2.08 ± 0.0001 31.04 
L. achyranthifolia 838.85 ± 2.05 2.91± 0.54 0.41 ± 0.00005 6.12 
S. arenarius 851.54 ± 1.74 6.95± 0.63 0.16 ± 0.00001 2.39 
T. densiflora 1147.90 ± 3.73 10.5± 2.03 0.08 ± 0.000003 1.24 
T. densiflora (R) 2315.52 ± 3.11 7.56± 0.71 0.05 ± 0.000004 0.75 
Results are means ± S.D. (n=3). 
(R) = roots 
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Table 3: Zone of inhibition (mm) produced by crude plant extracts of some Mexican flora from Oaxaca and standard 
antimicrobial agents. 
 Microbial strains 
Treatment S. aureus S. epidermidis K. pneumoniae E. coli P. mirabilis P. vulgaris C. albicans 
*Control (+) 22.75 ± 0.92 29.78 ± 1.62 29.56 ± 1.28 31.16 ± 1.93 23.03 ± 0.96 24.24 ± 1.52 21.45 ± 1.42 
A. aurantium 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 11.64 ± 1.18 9.98 ± 0.63 9.17 ± 2.21 
A. aurantium R 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 
A. cuspidata 16.56 ± 0.99 0 ± 0.00 0 ± 0.00 0 ± 0.00 15.35 ± 0.75 19.13 ± 1.91 0 ± 0.00 
A. subviscida 14.90 ± 0.74 15.44 ± 0.00 0 ± 0.00 10.03 ± 1.84 27.09 ± 1.83 27.37 ± 0.84 0 ± 0.00 
A. integrifolium 0 ± 0.00 0 ± 0.00 0 ± 0.00 7.02 ± 0.97 19.60 ± 1.44 16.35 ± 2.90 0 ± 0.00 
G. mexicanum 10.97 ± 0.99 0 ± 0.00 0 ± 0.00 0 ± 0.00 15.17 ± 1.58 16.38 ± 1.21 0 ± 0.00 
L. achyranthifolia 21.84 ± 0.93 0 ± 0.00 0 ± 0.00 7.44 ± 0.44 18.21 ± 1.52 17.19 ± 1.91 11.46 ± 0.92 
S. arenarius 15.66 ± 0.73 14.17 ± 0.00 0 ± 0.00 0 ± 0.00 14.64 ± 1.31 15.05 ± 0.79 13.26 ± 1.15 
T. densiflora  0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 9.6 ± 1.25 0 ± 0.00 
T. densiflora R 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 13.54 ± 0.51 15.38 ± 0.88 12.74 ± 1.64 
* Chloramphenicol (bacteria) and nystatin (fungus)  
Root indicated by "R". Results are means ± S.D. (n=3). 
 
 
Table 4: Minimal inhibitory concentration of crude plant extracts of some Mexican flora from Oaxaca and standard 
antimicrobial agents. 
 
 MIC x 10-3 (mg/ml) 
Treatment S. aureus S. epidermidis K. pneumoniae E. coli P. mirabilis P. vulgaris C. albicans 
*Control (+) 5.62 2.81 1.40 5.62 11.25 11.25 250000# 
A. aurantium ND ND ND ND 3125 6250 25000 
A. aurantium R ND ND ND ND ND ND ND 
A. cuspidata 97.65 ND ND ND 6250 12500 ND 
A. subviscida 781.2 390.6 ND 12500 781.1 390.6 ND 
A. integrifolium ND ND ND 25000 25000 6250 ND 
G. mexicanum 781.25 ND ND ND 6250 6250 ND 
L. achyranthifolia 78.12 ND ND 3125 3125 390.62 25000 
S. arenarius 56.25 130.85 ND ND 1046.87 1046.87 8375 
T. densiflora  ND ND ND ND ND ND 25000 
T. densiflora R ND ND ND ND 17500 8750 8750 
*Chloramphenicol (bacteria) and nystatin (fungus) 
Root is indicated by "R", ND: Not Determined, # (U/ml) 
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Antitopoisomerase activity 
 
The strain JN394 is DNA repair-deficient and drug-permeable (ise2 and rad52 mutations) (Nitiss and Wang, 
1988). These mutations increase the sensitivity of these cells to drugs. The yeast JN362a is a DNA repair-proficient 
strain (Nitiss and Wang, 1988). As shown in Figure 1, the strain JN394 was hypersensitive to CPT (-99.69±0.0 % 
growth) and ETP (-97.96±0.0 % growth), which are Topo I and Topo II poisons, respectively. A topoisomerase 
inhibitor affects the JN394 growth but does not inhibit JN362a growth (CPT 84.49%). Treatments with A. cuspidata 
(JN394, -71.23±2.12% and JN362a, 84.69± 3.54%), A. integrifolium (JN394, -81.19±2.12% and JN362a, 
126.06±12.02%), G. mexicanum (JN394, -34.28±7.07% and JN362a, 66.06±15.56%), and L. achyranthifolia  (JN394, -
49.74±3.54% and JN362a, 1.63±12.73%) showed similar behavior to CPT. A. aurantium, A. aurantium (R), T. 
densiflora and T. densiflora (R) were toxic extracts with different mechanisms of action to topoisomerase inhibition 
because of inhibited growth of JN394 and JN362a strains. A subviscida did not show growth inhibition on either strain. 
To find the topoisomerase inhibitor type, the extracts were tested with strain JN394t-1, which is isogenic to JN394 and 
contains a disrupted topI gene (Nitiss and Wang, 1988).  The absence of the gene resulted in diminished cytotoxicity of 
antitopoisomerase I drugs. As shown in Figure 2, CPT topo I poison failed to reduce the growth of these mutant cells 
(76.50±2.12%); similar behavior is observed with G. mexicanum (35.31±6.36%).  Therefore, the Topo I enzyme is the 
target of this extract. In contrast, when topI cells were treated with antitopoisomerase II ETP (-99.08% growth) no 
resistance was observed. The extracts that showed growth inhibition of JN394t-1 strain were A. cuspidata (-
30.88±0.0%), A. integrifolium (-38.11±4.95%), and L. achyranthifolia (-70.97±12.02%). Sensitivity in the topI cells 
was higher than in the parent cells (JN394). This finding provided evidence that Topo I was not the cellular target of 
these plant extracts.  
The strain JN394t2-5 expresses at 25 °C the mutation top2-5, which consists of changing three different amino 
acid II TOP domains which are important in the interaction of protein with topoisomerase II poison. Thus, the strain 
has a resistance at 25 °C to active compounds with topoisomerase II poison (Jannatipour et al., 1993). Figure 2 shows 
that cells with the top2-5 mutation can grow in ETP (55.77±3.54%). The sensitivity of the top2-5 strain to CPT (-
100.00±0.00 %) and SBZ (-38.46±7.07%) is shown in Figure 2. The strain has essentially the same sensitivity to CPT 
as JN394 (rad52 top2+ cells), indicating that the observed resistance is specific to antitopoisomerase II agents. Among 
the plant extracts tested, none showed similar behavior to ETP. This means that none of the extracts exhibited 
antitopoisomerase II poison activity. Plant extracts of A. cuspidata (-15.38 ± 2.83%), A. integrifolium (-17.31 ± 2.12%) 
and L. achyranthifolia (-61.54 ± 4.24%) were shown to have topoisomerase II catalytic inhibitors compounds. 
To complete the analysis, we also used the yeast strain JN394t2-4, that expresses the temperature-sensitive top2-4 
mutant in place of the wild type top2 gene (Jensen et al., 2000, Nitiss and Nitiss, 2001). JN394t2-4 cells have problems 
growing at 30 °C, because topoisomerase II activity at this temperature is reduced (DiNardo et al., 1984; Dong et al., 
2000). Figure 2 shows that cells with the top2-4 mutation at 25oC can grow with ETP (18.29 %) and SBZ (25.14 %), 
but they are sensitive to CPT (-40.57 %). Cells were hypersensitive at 30oC, displaying cytotoxicity with CPT (-
85.45%), ETP (-69.35 %) and SBZ (-81.89 %). Similar behavior was observed for extracts of A. cuspidata, A. 
integrifolium.  L. achyranthifolia showed no growth inhibition at 25°C (8.57 to 44.57%), but at 30°C, growth was 
inhibited (-63.47 to -72.29 %).  
 
Figure 1: Effects of controls CPT (camptothecin topo I inhibitor), and ETP (etoposide topo II poison), and extracts on 
JN394 (30°C) and JN362a (30°C) growth. Treatments with similar behaviors to CPT or ETP are A. cuspidata, A 
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integrifolium, G. mexicanum, and L. achyranthifolia, which inhibited growth of JN394 and promoted or did not affect 
that of JN362a.  A. aurantium, A. aurantium R, T. densiflora and T. densiflora R were toxic to both strains. 
 
Figure 2: Effects of controls CTP (camptothecin topo I inhibitor), ETP (etoposide topo II poison), and SBZ 
(Sobuzoxane topo II inhibitor), and extracts from A. cuspidata, A. integrifolium, G. mexicanum, and L. achyranthifolia 
on JN394t-1 (30°C), JN395t2-5 (25°C), JN394t2-4 (25°C), and JN394t2-4 (30°C) growth. G. mexicanum was identified as 
topoisomerase inhibitor I, meanwhile these extracts showed similar behavior to that of SBZ, a topo II inhibitor 
(catalytic). JN395t2-5 (25°C), JN394t2-4 (25°C), and JN394t2-4 (30°C) assays with G. mexicanum were not determinate 
(ND). 
  
Antitopoisomerase activity of fractions and sub-fractions of A. cuspidata 
 
Growth inhibition of JN394 and JN362a cells was observed with AaA1 (both strains -100 % growth) and 
AaA17 sub-fractions (-24.57 and -27.2%, respectively) (Table 5). However, both fractions exhibited active cytotoxic 
mechanisms different from topoisomerase inhibition. Fractions (Table 4) with similar behavior to CPT or ETP were 
AaA7 (at 336 μg/mL) and AaA8 (at 583 μg/mL) due to the growth inhibition on JN394 (-20.15±11.58% and -
43.10±2.58%, respectively) and no growth inhibition on JN362 (27.09±12.14% and 9.56±5.06%, respectively). These 
are the fractions with antitopoisomerase activity, which showed no toxicity to JN394t-1 (-8.11±3.12 and 32.73±2.55 %) 
and JN394t2-5 (0.75±5.45 and 29.38±1.96%), where the first strain has diminished cytotoxicity of topo I inhibitors and 
the second one has a resistance at 25°C to antitopoisomerase II compounds. Thus, AaA7 and AaA8 contain topo I and II 
inhibitors. Chromatographic separation showed behavior similar to CPT (15.84±1.11%, -89.37±3.57%) with JN394t-1 
and JN394t2-5 25°C strains (Figure 3); thus, sub-fraction (-23.42±4.30%, -61.28±6.86%) was toxic to JN394t-1 and 
JN394t2-5; therefore, it contains topo II inhibitors (Figure 3). 
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Table 5:  Percentage of growth of JN394, JN362a, JN394 t-1, and JN394t2-5 strains from A. cuspidata fractions. 
 
Fraction 
Concentration 
μg/mL  JN394 
30°C 
JN362a 
30°C 
 
JN394t-1 
30°C 
 
 
JN394t2-5 
25°C 
CPT 50 -100.00±0.00 39.60±6.40 15.84±1.11 -89.37±3.57 
ETP 100 -99.76±0.42 5.00±3.67 -85.53±8.35 27.88±4.51 
AaA1 0.16µL -100.00±0.00 -100.00±0.00 ND ND 
AaA2 501 -10.58±2.36 -4.81±3.94 ND ND 
AaA3 685 -14.07±4.94 -8.50±4.00 ND ND 
AaA4 111 -9.33±1.90 -11.42±2.08 ND ND 
AaA5 99 19.67±14.05 ND ND ND 
AaA6 319 -27.19±13.23 -93.60±2.45 ND ND 
AaA7 336 -20.15±11.58 27.09±12.14 -8.11±3.12 0.75±5.45 
AaA8** 583 -43.10±2.58 9.56±5.06 32.73±2.55 29.38±1.96 
AaA9 514 -16.51±1.72 -6.76±5.33 ND ND 
AaA10 253 54.00±40.58 ND ND ND 
AaA11 293 12.74±4.22 ND ND ND 
AaA12 293 21.55±31.67 ND ND ND 
AaA13 223 21.91±17.75 ND ND ND 
AaA14 302 19.65±13.13 ND ND ND 
AaA15 296 59.43±17.60 ND ND ND 
AaA16 166 9.95±13.29 ND ND ND 
AaA17 164 -24.57±7.09 -27.20±7.47 ND ND 
AaA18 306 27.90±11.95 ND ND ND 
AaA19 287 11.25±13.64 ND ND ND 
AaA20 144 59.00±66.91 ND ND ND 
AaA21 267 7.14±5.13 ND ND ND 
aValues are means ± SD of triplicate determinations.  
ND: Not Determined.  
**Topo I and II inhibitors 
 
 
Figure 3: Effects of controls CTP (topo I inhibitor, 50μg/mL), and ETP (topo II poison 100μg/mL), and the 
subfractions AaA8a (154μg/mL), AaA8b (154μg/mL), Aa8c(213μg/mL), AaA8d (154μg/mL), AaA8e (154μg/mL) and 
AaA8f (63.9μg/mL) on the JN394 (30°C), JN362a (30°C), JN394t-1 (30°C), and JN394t2-5 (25°C) growth. AaA8b and 
AaA8e showed behavior as topo I inhibitors (*) while AaA8d showed behavior as a topo II inhibitor (§) 
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Mutagenicity test 
 
Three extracts at 10 mg/mL resulted in significant reductions in the viability of Salmonella typhimurium and 
all extracts at 5 mg/mL had no significant effect on the bacterial viability. Therefore, we decided to proceed with 5 
mg/mL, which is well below any concentration that could compromise the bacterial viability. Table 6 shows the 
number of His+ revertant colonies with and without S9 activation against S. typhimurium tester strain TA1535 for all 
extracts. His+ revertant colonies/plate of all extracts without S9 mix (S9-) were < 27.7±1.8, a value less than twice that 
of the negative control, therefore extracts are not direct mutagens. When the extracts are tested in the presence of S9 
(S9+), which mimics in vivo an activation metabolic process (Ames et al., 1973), none of the extracts showed a His+ 
revertant colonies/plate number large enough to characterize extracts as indirect mutagens (His+ revertant 
colonies/plate <31.3).  
 
Table 6: Mutagenic effect of different extracts (5 mg/mL) using Salmonella typhimurium TA1535 with and without S9 
metabolic activation 
Treatment Concentration His+ revertant 
colonies/plate 
Control ----- 27.6 ± 1.4 
NaN3 1μ g/plate 297.7 ± 16.8* 
B[a]P 20μM/plate 350.3 ± 10.1* 
 His+ revertant 
colonies/plate 
His+ revertant 
colonies/plate 
S9- S9+ 
A. aurantium 18.0 ± 1.2 21.0 ± 2.1 
A. aurantium (R) 21.7 ± 2.4 25.3 ± 4.2 
A. cuspidata 15.7 ± 1.8 20.3 ± 1.5 
A. subviscida 26.0 ± 3.2 31.0 ± 2.1 
A. integrifolium 30.3 ± 0.9 30.3 ± 5.0 
G. mexicanum 21.7 ± 2.7 18.3 ± 2.6 
L. achyranthifolia 23.3 ± 1.5 25.3 ± 2.2 
S. arenarius 27.7 ± 1.8 31.3 ± 2.2 
T. densiflora 24.7 ± 3.5 26.7 ± 4.5 
T. densiflora (R) 18.7 ± 2.6 20.0 ± 1.5 
Number of His+ revertant colonies/plate: mean values of three replicates 
B[a]P = Benzopyrene 
(R) = Root 
S9- refers to assay without metabolic activation; S9+ refers to assay with metabolic activation 
S. typhimurium TA1535 without treatment differs significantly from control (P<0.05) (spontaneous mutation). 
 
Discussion 
 
Among the species that were studied, the S. arenarius and L. achyranthifolia extracts showed significant 
antimicrobial activity (< 100 μg/mL) (Cos et al., 2006) against S. aureus with MIC values of 56.25 and 78.12 μg/mL 
respectively. Cyclitol-2-methoxy-5-hydroxymethyl cyclopentane-1,3,4-triol with parasympathomimetic activity was 
described from flowers of S. arenarius (Pérez-Gutiérrez and Pérez-Gutiérrez, 1992) but there are no reports about 
antimicrobial activity for this species. On the other hand, studies of L. achyranthifolia described the isolation of two 
furanonaphthoquinones: diodantunezone and isodiodantunezone (Abeygunawardena et al., 1991) from roots, and 
eighteen monoterpenes from essential oils (Hernández et al., 2005). Essential oils, and ethanol, chloroform and n-
hexane extracts were weakly toxic to eleven pathogenic bacteria strains, including S. aureus, whose MIC value was 1.0 
mg/mL (Hernández et al., 2003). We found significant activity of methanol extract against S. aureus with a MIC of 
78.12 μg/mL. The differences in MIC values observed could be due to the solvents used for the extract preparation 
(chloroform, hexane and ethanol) and the disc-diffusion and well-diffusion methods used for treatments that do not 
easily diffuse into agar. Topoisomerase (type II catalytic) inhibition has not been described for extracts or compounds 
from the Lantana genus.  
Some species of Acalypha genus (Euphorbiaceae) have been described as useful in the treatment of conditions 
related to infections and inflammation (Hassan-Abdallah et al., 2013; Hernández et al., 2003). Among the biological 
studies reported for Acalypha genus, there are antimicrobial compounds (Emeka et al., 2012; Alade et al., 1993) and 
cytotoxic compounds (Amarnath et al, 2014; Lim et al., 2011). Weak to moderate antimicrobial activity was reported 
from A. cuspidata leaf and stem methanolic extracts against five methicillin-resistant Staphylococcus strains (Rocha-
Gracia et al., 2011). However, A. cuspidata showed a MIC value of 97.65 µg/mL against S. aureus and catalytic 
antitopoisomerase II activity (at 50 μg/mL). The antitopoisomerase activity of Acalypha genus has not been described, 
although there is a report about the probable antitopoisomerase II activity of A. wilkesiana extracts, which induce 
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apoptosis by single and double strand DNA breaks (Lim et al., 2011).  Chemical studies of the Acalypha genus 
demonstrated the presence of sesquiterpenes and diterpenes (Siems et al., 1996).  Thus, the observed antimicrobial and 
antitopoisomerase activities could be due to these compounds, which are known for biological activities such as those 
observed for the diterpene ingenol.  Ingenol, isolated from the Euphorbiaceae family, exerts antimicrobial and 
antitopoisomerase type II activities (Miyata et al., 2006).    
Fractionation of A. cuspidata extract led to the identification of the following: 
i) The toxic fractions to S. cerevisae cells: AaA1 (at 0.16μL/mL) and Aa17 (at 164 μg/mL) (Table 4) which is activity 
unrelated to topoisomerase inhibition; 
ii) Two antitopoisomerase fractions AaA7 (at 336 μg/mL) and AaA8 (at 583 μg/mL); (AaA8 which had a better yield 
(1.69%) was subjected to chromatographic separation); 
iii) Two subfractions AaA8d and AaA8e (at 154 μg/mL) with similar antitopoisomerase activity (-99.07±0.89 and -
84.10±9.22%) to 50 μg/mL CPT (-100±0.0) and 100 μg/mL ETP (-99.76±0.42%) on JN394 strain (Figure 3); 
iv) Two subfractions AaA8b and AaA8e with topo I inhibitors and a subfraction AaA8d containing topo II inhibitors; 
v) The overall effect of the A. cuspidata extract as a topo II inhibitor but with fractions and sub-fractions showing topo 
I, topo II or both mechanisms. 
A. subviscida showed no significant antimicrobial or antitopoisomerase activities but exhibited the best antiradical 
efficiency (AE = 31.04%). 
Anti-inflammatory activity and antibacterial effects have been described against S. aureus (MIC 67μg/mL), and 
Bacillus subtilis (MIC 67μg/mL) of hexane and chloroform G. mexicanum extracts (Bolívar et al., 2011). The current 
study is the first to report that methanolic extract of G. mexicanum showed antitopoisomerase type I activity. 
Methanol extract of A. integrifolium, which is used in the treatment of diabetes in Mexico (Andrade-Cetto and 
Heinrich, 2005), showed no significant antioxidant (AE = 4.18 %) or antimicrobial activities (MIC ≥ 6250 µg/mL), but 
it displayed antitopoisomerase type II activity. The isolation of an acetylene compound containing seventeen carbon 
atoms from stems of A. integrifolium (Bohlmann and Zdero, 1976) could explain the biological activity observed, 
because these metabolites display important biological activities such as anticancer, antibacterial, antifungal, among 
others (Kuklev et al., 2013). Another Asteraceae species studied was A. aurantium, whose extracts, from roots and 
stems, showed no significant antioxidant (EA = 1.19 %), antimicrobial (MIC ≥ 3125 µg/mL) or antitopoisomerase 
activities. In this work, neither A. aurantium nor the T. densiflora methanolic extracts showed growth inhibition of S. 
cerevisae JN394 and JN362a strains, meaning that they are cytotoxic through a mechanism different from 
topoisomerases inhibition. The toxicity of A. aurantium extract agrees with the toxic effects observed on Alternaria 
alternata and Fusarium solani (Lira-De León et al., 2014). The biological activity of A. aurantium is probably because 
it contains α-terthienyl and 5-(4´´-hydroxy-1´´-butynyl)-2-2´-bithiophene (Herrera-Martínez et al., 2016), which are 
known for their antiviral, cytotoxic (Hudson et al., 1989), antiamoebic (Herrera-Martínez et al., 2016), and fungicidal 
activities (Kourany and Arnason, 1988).  
In Mexico, many vegetal species are used as complementary and alternative medicines with the constant or 
frequent consumption by sick people of extracts which have generally unknown mutagenic potential.  None of the plant 
extracts tested in this work showed mutagenic effects at 5 mg/mL using S. typhimurium TA1535 strain. This evaluation 
was particularly significant for those vegetal species such as S. arenarius and A. integrifolium, which are known as 
hypoglycemic (Andrade-Cetto and Heinrich, 2005) and are used for the treatment of chronic diseases. However, more 
toxicity assays are needed to assure that the plant extracts tested in this work can be used safely.  
 
Conclusions  
 
In this work, we identified four plant species with antitopoisomerase and non-mutagenic activities, and 
consequently with anticancer potential: A. cuspidata, A. integrifolium, G. mexicanum, and L. achyranthifolia (Figure 4). 
None of these plants showed significant toxic effects (MIC>390 μg/mL) against growth of the Gram-negative bacteria 
tested or the fungus C. albicans. They also showed no antioxidant activity. Only L. achyranthifolia and S. arenarius 
showed significant antimicrobial activity (< 100 μg/mL) against S. aureus. We obtained three antitopoisomerase sub-
fractions from A. cuspidata, demonstrating increasing activity at concentrations similar to reference substances (CPT 
and ETP). Therefore, further work is required to isolate the phytochemicals responsible for the observed activities.  In 
addition, more extensive experimentation is needed to evaluate the toxicity to JN394 and JN362a strains caused by T. 
densiflora, A. aurantium, and two fractions of A. cuspidata (AaA1 and AaA17). The current work represents the first 
report on the topoisomerase enzyme inhibition of extracts from Alloispermum, Acalypha and Galium genus. 
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Figure 4: A. cuspidata, G. mexicanum, A. integrifolium and L. achyranthifolia images 
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